Meeting

Virtual Roundtable: What a World Without Chevron Means for U.S. Health

Tuesday, February 13, 2024
REUTERS/Jonathan Erns
Speaker
Nicholas Bagley

Thomas G. Long Professor of Law, University of Michigan Law School

Presider

Bloomberg Chair in Global Health; Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council on Foreign Relations

Global Health, Economics, and Development Roundtable Series, Global Health Program, and Renewing America

In January, the U.S. Supreme Court debated whether to overturn Chevron v. Natural Resources Defense Council—one of the most cited U.S. cases of all time, which established the principle that the courts should defer to federal agencies when they interpret the law in the course of carrying out their duties. During the COVID-19 pandemic, the deference owed to federal agencies’ exercise of public health authorities was already heavily litigated. How much overruling Chevron would alter U.S. health policymaking is a matter of debate, with some claiming the change would be modest while others argue that FDA decision-making and Medicare administration would be rendered unworkable.

Mr. Nicholas Bagley, the Thomas G. Long Professor of Law at Michigan Law and an expert on administrative law and health law, and Thomas J. Bollyky discuss what replacing the Chevron doctrine might mean for U.S. health.

Top Stories on CFR

Ukraine

The new U.S. aid package will reestablish a critical flow of weapons to Ukraine’s military, but the war will hinge greatly on which side can ramp up and sustain its firepower and troop numbers in the months ahead.  

RealEcon

The World Bank and IMF have concluded their spring meetings, but questions remain on China, lending capacity, and balancing the interests of rich and poor countries.

Mexico

Organized crime’s hold on local governments fuels record election violence; Europe’s cocaine pipeline shifting to the Southern Cone.